“Primary Analysis of Phase 2 Results for Cemiplimab in Patients With Metastatic Basal Cell Carcinoma Who Progressed on or Were Intolerant to Hedgehog Inhibitors”. SKIN The Journal of Cutaneous Medicine 7, no. 2 (March 13, 2023): s177. Accessed April 19, 2025. https://skin.dermsquared.com/skin/article/view/2002.